MSFT vs RTX: Which Is the Better Buy?

Side-by-side comparison of Microsoft Corporation and RTX Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-18.
Microsoft Corporation Β· Technology
$497.12
+41.3% upside to fair value
High Conviction Grade A High Quality
VS
RTX Corporation Β· Industrials
$193.54
+33.0% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
MSFT has more upside to fair value (+41.3%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MSFT RTX
Current Price $497.12 $193.54
Fair Value Estimate $702.35 $257.36
Upside to Fair Value +41.3% +33.0%
Market Cap $3,691.4B $260.9B
Forward P/E β€” β€”
EV / EBITDA 18.3x 18.1x
Price / Sales 11.1x 2.8x
Price / FCF 55.1x 21.7x
Revenue Growth YoY +17.7% +14.5%
Gross Margin 67.9% 20.3%
Operating Margin 46.8% 11.2%
Return on Equity 33.2% 11.8%
Dividend Yield 0.73% 1.46%
FCF Yield 1.81% 4.6%
Analyst Consensus Strong Buy Buy
Investment Thesis
MSFT β€” Microsoft Corporation
Microsoft is a global infrastructure-software platform spanning Azure, Microsoft 365, security, Dynamics, Windows, GitHub and AI copilots, with high business quality supported by enterprise distribution, explicitly cited switching costs, a $678 billion commercial RPO balance, 67.9% TTM gross margin, 46.8% TTM operating margin, 40.3% TTM net margin and 33.2% ROE. Revenue grew 17.7% and earnings gr…
RTX β€” RTX Corporation
RTX Corporation is a $260.85 billion aerospace and defense conglomerate operating three segments β€” Collins Aerospace, Pratt & Whitney, and Raytheon β€” serving commercial aviation, military, and government customers worldwide with 180,000 employees. The business quality is high: it holds intangible-asset and switching-cost advantages rooted in long-cycle engine programs, proprietary defense electro…
Accumulation Zones
Metric MSFT RTX
Zone Low $526.76 $193.02
Zone High $597.00 $218.76
In Buy Zone? Yes Yes
← MSFT Research    RTX Research β†’    All Research